Chronic inflammation and vascular cell plasticity in atherosclerosis

Area of Science:

• Cardiovascular Research
• Cell Biology
• Immunology

Background:

• Atherosclerosis involves dynamic changes in vascular cells (smooth muscle cells, endothelial cells, macrophages) driven by chronic inflammation.
• The inflammatory hypothesis of atherosclerosis is supported by clinical trials showing anti-inflammatory therapy reduces cardiovascular events.
• Current therapies do not specifically target the diverse phenotypes of cells within atherosclerotic plaques.

Purpose of the Study:

• To review vascular cell plasticity within the atherosclerotic plaque microenvironment.
• To emphasize the link between vascular cell phenotype, plaque inflammation, and lesion stability.
• To propose modulating plaque cell phenotype as a new therapeutic approach for atherosclerosis.

Main Methods:

• Review of existing literature on vascular cell plasticity in atherosclerosis.
• Analysis of evidence linking cell phenotype to plaque inflammation and stability.
• Discussion of therapeutic implications of targeting cell phenotypes.

Main Results:

• Vascular cell phenotypic conversions are integral to atherosclerosis progression and inflammation.
• Cellular plasticity within plaques is closely tied to inflammation and lesion stability.
• Understanding cell behavior during therapy is crucial for effective treatment.

Conclusions:

• Vascular cell plasticity is a key factor in atherosclerosis, influenced by the inflammatory microenvironment.
• Targeting the phenotype of plaque cells presents an unexplored therapeutic avenue.
• Further research is needed to understand and manipulate cell phenotypes for atherosclerosis treatment.